Comparison of Bone Effects With Copaxone [glatiramer acetate] and Interferon in Multiple Sclerosis: A Pilot Study.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Glatiramer acetate; Interferon beta-1a; Interferon beta-1b
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- 22 Jan 2014 Biomarkers information updated
- 24 Sep 2012 Planned end date changed from 1 Feb 2009 to 1 Jan 2013 as reported by ClinicalTrials.gov.
- 05 Nov 2008 Planned end date changed from 1 Mar 2009 to 1 Feb 2009 as reported by ClinicalTrials.gov.